MedPath

TRIMO SAN

Trimo San

Approved
Approval ID

1e4a1caa-e6ba-44ef-8347-07e6385a7c9e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 17, 2022

Manufacturers
FDA

CooperSurgical, Inc.

DUNS: 801895244

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxyquinoline Sulfate and Sodium Lauryl Sulfate

PRODUCT DETAILS

NDC Product Code59365-5030
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationVAGINAL
Effective DateJune 16, 2022
Generic NameOxyquinoline Sulfate and Sodium Lauryl Sulfate

INGREDIENTS (6)

SODIUM LAURYL SULFATEActive
Quantity: 0.1 mg in 1 g
Code: 368GB5141J
Classification: ACTIB
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
TROLAMINEInactive
Code: 9O3K93S3TK
Classification: IACT
OXYQUINOLINE SULFATEActive
Quantity: 0.25 mg in 1 g
Code: 61VUG75Y3P
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TRIMO SAN - FDA Drug Approval Details